Skip to main content
Morepen Laboratories Ltd. logo

Morepen Laboratories Ltd. — Investor Relations & Filings

Ticker · MOREPENLAB ISIN · INE083A01026 LEI · 335800OJZDFHFQJ4HP35 BSE.NS Manufacturing
Open in API
Filings indexed 1,661 across all filing types
Latest filing 2021-03-25 Capital/Financing Update
Country IN India
Listing BSE.NS MOREPENLAB

About Morepen Laboratories Ltd.

https://www.morepen.com

Morepen Laboratories Ltd. is a research-led company specializing in the development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), home diagnostic devices, and finished formulations. The company maintains a significant global presence, exporting high-quality APIs such as Loratadine, Montelukast, Atorvastatin, and Fexofenadine to numerous international markets. Its diagnostic division, branded as Dr. Morepen, is a prominent player in the home healthcare segment, offering a wide range of products including digital glucometers, blood pressure monitors, and nebulizers. Morepen operates manufacturing facilities compliant with international regulatory standards, including USFDA approvals. The company focuses on leveraging its R&D capabilities to deliver healthcare solutions and maintains a diverse portfolio across various therapeutic areas including cardiovascular, anti-diabetic, and anti-asthmatic treatments.

Recent filings

Filing Released Lang Actions
outcome of board meeting held on 25.03.2021
Capital/Financing Update Classification · 95% confidence The document is a formal communication addressed to stock exchanges regarding the outcome of a Board of Directors meeting. It announces the approval of allotment of fully convertible warrants on a preferential basis to promoter group entities. The content focuses on capital raising through issuance of warrants and details of the allotment. There are no financial statements or detailed financial analysis present, nor is this a full report. The document is an update on financing activity and capital structure changes. The length is 4228 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, the document fits best under Capital/Financing Update (CAP).
2021-03-25 English
Outcome of Board Meeting
Capital/Financing Update Classification · 90% confidence The document is very short (1063 characters) and contains a formal letter regarding warrants entitling allottees to apply for equity shares upon payment. It is signed by the Company Secretary and requests the recipient to take the information on record. There is no detailed financial data, no mention of a report being attached or published, and no regulatory or audit content. The content is an announcement related to share allotment rights, which aligns with capital or financing updates. Given the nature of the content about warrants and equity shares, the most appropriate classification is Capital/Financing Update (CAP).
2021-03-25 English
Intimation of loss of share certificates.
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (NSE and BSE) regarding the loss of share certificates and the request for issuance of duplicate share certificates. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulation 39(3). The content is about notifying the exchange of a shareholder's lost share certificates and does not contain financial data, management discussion, or report publication. It is an official regulatory communication about share certificate loss, which does not fit into financial reports, earnings, or management information categories. It is best classified under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2021-03-24 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (NSE and BSE) regarding the loss of share certificates by shareholders and the request for issuance of duplicate share certificates. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulation 39(3). The content is about notifying the exchange of a specific event related to share certificates, not a financial report, earnings release, or management discussion. It is a regulatory announcement about share certificate loss and related administrative action. The document length is short (2922 characters), and it is not a report or presentation but an official notification. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-03-24 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the loss of share certificates and the request for issuance of duplicate share certificates. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate loss and related disclosures. The content is an official notification about a shareholder's lost share certificates and does not contain financial data, management discussion, or report content. It is an announcement related to shareholding but specifically about lost share certificates and duplicate issuance, which does not fit into major shareholding notification or director dealings. It is a regulatory announcement related to compliance and disclosure requirements. The document length is short (2524 characters) and is a formal notification letter, not a report or financial statement. Therefore, the best fitting category is Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2021-03-18 English
Please find attached herewith letters received from Registrar and Share Transfer Agent (viz., Mas Services Limited) of the Company regarding loss of share certificates of the Company.
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (NSE and BSE) regarding the loss of share certificates and the request for issuance of duplicate share certificates. It references Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate loss and related disclosures. The content is an official notification about share certificate loss, not a financial report, earnings release, or management discussion. It does not contain financial data or results, nor does it announce voting results or capital changes. This type of document fits best under Regulatory Filings (RNS) as it is a compliance-related disclosure to the stock exchanges about share certificate loss.
2021-03-18 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.